BIB SEC Filings — ProShares Ultra Nasdaq Biotechnology

Data updated: 2026-08-14

51 SEC filings are listed: 16 prospectuses (latest Apr 7, 2025), 27 quarterly N-PORT holdings reports (latest Jul 28, 2026) and 8 annual N-CEN reports (latest Aug 14, 2026).

BIB Prospectus (485BPOS / 497)

Objective, strategy, fees and risks. 16 filings on SEC EDGAR.

BIB Portfolio holdings (N-PORT)

Full holdings and monthly flows, filed quarterly. 27 filings on SEC EDGAR.

BIB Annual census (N-CEN)

Service providers, brokerage and operations. 8 filings on SEC EDGAR.

Browse every ProShares Ultra Nasdaq Biotechnology filing on SEC EDGAR

Data Sources

ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, and annual data from Form N-CEN.

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.